Published by Michele Maatouk on 11th June 2024
(Sharecast News) - Citi lifted its price target on Hikma Pharmaceuticals on Tuesday to 2,845p from 2,770p as it said IQVIA April data highlighted "healthy trends" for injectables and US Generics.
URL: http://www.digitallook.com/dl/news/story/34352513/...